Synonyms: Compound S-D1 [WO2021155225A1] | FHD609
Compound class:
Synthetic organic
Comment: FHD-609 is a PROTAC degrader of bromodomain-containing protein 9 (BRD9), that was designed as a treatment for synovial sarcoma and SMARCB1-loss tumours. It is one of the compounds claimed in Foghorn Therapeutics' patent WO2021155225A1 [1]. FHD-609 is suitable for intravenous delivery.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
Ligand families/groups | PROTACs, molecular glues and other degraders |
Synonyms ![]() |
Compound S-D1 [WO2021155225A1] | FHD609 |
Database Links ![]() |
|
GtoPdb PubChem SID | 483123307 |
PubChem CID | 156817975 |
Search Google for chemical match using the InChIKey | OBNRBCUHEAAFPS-KDXMTYKHSA-N |
Search Google for chemicals with the same backbone | OBNRBCUHEAAFPS |
UniChem Compound Search for chemical match using the InChIKey | OBNRBCUHEAAFPS-KDXMTYKHSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | OBNRBCUHEAAFPS-KDXMTYKHSA-N |